Bill & Melinda Gates Foundation and CSIR, India sign MoU to promote health research


Deprecated: strlen(): Passing null to parameter #1 ($string) of type string is deprecated in /home/medicircle/public_html/script_newsdetails.php on line 75
▴ Bill & Melinda Gates Foundation and CSIR, India sign MoU to promote health research
Bill & Melinda Gates Foundation and CSIR, India have signed a MoU to support the development, conduct and promotion of health research in India.

Gates Foundation and CSIR will work together to identify opportunities to initiate scientific and technological collaborations. These will focus on developing and testing new preventions, therapies and interventions that can help to solve major health concerns that affect India and other developing countries. As per the MoU, areas of research collaboration would include genetic diseases that impact infant and neonatal mortality, new diagnostics and devices for infectious disease and environmental surveillance, development of cost-effective processes for drug, vaccines, biologics, and diagnostics manufacturing novel, microbiome-directed foods, socio-economic impact of science and technological tools and other areas of health and development.

The MoU was signed by Hari Menon, Director, India Country Office on behalf of Bill & Melinda Gates Foundation and Dr G N Dayananda, Head, Technology Management Directorate – Industry Interface, CSIR. Talking about the importance of this collaboration, Hari Menon stated, “Under this MOU, we look forward to collaborating with CSIR on many important themes linked to India’s health and development priorities. We are excited about the innovation potential of CSIR's wide network and the promise of our partnership to develop innovative tools and solutions for public health challenges in India and globally.”

On the occasion of the signing of the MoU, DG-CSIR, Dr Shekhar C Mande, commented 'The opportunity to work closely with Gates Foundation on broad spectrum of activities in health and development, will accelerate the R&D and implementation of innovations in the coming years that are not only relevant to India but to the world’.

Tags : #BillMelindaGatesFoundation #CSIRIndia #India #LatestPharmaNews19thFeb #PromotionofHealthResearchinIndia #GeneticDiseases

About the Author


Team Medicircle

Related Stories

Loading Please wait...

-Advertisements-




Trending Now

Digital Identity Fraud in Healthcare: What India Must KnowNovember 18, 2026
Wearables in Clinical Care: When Should Doctors Trust the Data?November 18, 2026
Cybersecurity for Medical Startups: What Founders MissNovember 18, 2026
Remote Patient Monitoring: The Next Phase of Virtual CareNovember 18, 2026
Digital Health Wallets: Future of Medical Records in IndiaNovember 17, 2026
How Hospitals Can Prepare for a Transparent Healthcare MarketNovember 17, 2026
Childhood Nutrition: Understanding Micronutrient Gaps Beyond CaloriesNovember 16, 2026
Anaemia in Adolescent Girls: Connecting Prevention, Testing and Nutrition SupportNovember 16, 2026
Health Information Exchanges in India: Are Medical Records Finally Going Portable?November 16, 2026
Hospital Accreditation in 2026: What Is Changing Beyond the Checklist?November 16, 2026
Digital Insurance Platforms and India's Health Coverage FutureNovember 14, 2026
ABDM 2.0: India's Digital Health Ecosystem FutureNovember 14, 2026
Vaccine Cold-Chain Management: Protecting Immunisation Quality From Storage to DeliveryNovember 14, 2026
Foodborne Illness Surveillance: How Public Health Systems Track RisksNovember 14, 2026
Interoperability in Indian Healthcare: Why Patient Data Still StrugglesNovember 13, 2026
Tuberculosis Contact Screening: How Preventive Care Works Around ExposureNovember 13, 2026
COPD Care in India: Linking Diagnosis, Inhaler Education and Follow-UpNovember 13, 2026
Management of ANCA Glomerulonephritis: Induction & Maintenance ProtocolsNovember 12, 2026
Smart Hospital Command Centres Transforming IndiaNovember 12, 2026
Gamma Knife Surgery in India: What You Need to KnowNovember 12, 2026